Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 3/20 | 0.64 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.64 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.64 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | FAAH | O00519 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | CNR1 | P21554 | 1/20 | 0.61 |
| ▸ | CNR2 | P34972 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.55 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.49 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.49 |
| ▸ | DGKA | P23743 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18623385 | 1.00 | PRKCA (0.64) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL18623387 | 1.00 | PRKCA (0.64) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL18623379 | 1.00 | PRKCA (0.64) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL16637584 | 0.91 | PRKCA (0.77) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL18623408 | 0.91 | PRKCA (0.77) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL16637585 | 0.91 | PRKCA (0.77) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL18623378 | 0.91 | PRKCA (0.77) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL18623407 | 0.91 | PRKCA (0.77) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL18632816 | 0.91 | MAPT (0.63) | PRKCAPRKCEPRKCQPRKCDMAPT | |
| SCHEMBL18632818 | 0.91 | MAPT (0.63) | PRKCAPRKCEPRKCQPRKCDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230380435-A1 | METHOD FOR PREPARING AND PRESERVING SANITIZED PRODUCTS | APEEL TECHNOLOGY, INC. | 2023-11-30 | — | — | US | disclosed |
| US-11767278-B2 | Plant extract compositions for forming protective coatings | APEEL TECHNOLOGY, INC. (US) | 2023-09-26 | — | — | US | disclosed |
| US-11723377-B2 | Method for preparing and preserving sanitized products | APEEL TECHNOLOGY, INC. (US) | 2023-08-15 | — | — | US | disclosed |
| US-20230232872-A1 | COMPOUNDS AND FORMULATIONS FOR PROTECTIVE COATINGS | APEEL TECHNOLOGY, INC. | 2023-07-27 | — | — | US | disclosed |
| US-11641865-B2 | Compounds and formulations for protective coatings | APEEL TECHNOLOGY, INC. (US) | 2023-05-09 | — | — | US | disclosed |
| US-20180222835-A1 | Plant Extract Compositions for Forming Protective Coatings | APEEL TECHNOLOGY, INC. | 2018-08-09 | — | — | US | disclosed |
| US-20180179401-A1 | Precursor Compounds for Molecular Coatings | APEEL TECHNOLOGY, INC. | 2018-06-28 | — | — | US | disclosed |
| US-9957215-B2 | Plant extract compositions for forming protective coatings | APEEL TECHNOLOGY, INC. (US) | 2018-05-01 | — | — | US | disclosed |
| US-20180044276-A1 | PLANT EXTRACT COMPOSITIONS FOR FORMING PROTECTIVE COATINGS | APEEL TECHNOLOGY, INC. | 2018-02-15 | — | — | US | disclosed |
| US-20170332650-A1 | METHOD FOR PREPARING AND PRESERVING SANITIZED PRODUCTS | APEEL TECHNOLOGY, INC. | 2017-11-23 | — | — | US | disclosed |
| US-20170073532-A1 | Precursor compounds for molecular coatings | APEEL TECHNOLOGY, INC. | 2017-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180222835-A1 | Plant Extract Compositions for Forming Protective Coatings | CUTA, SHARPIN, BROX | PRKCA 1628/4885PRKCE 1133/4885PRKCQ 1529/4885 |
| US-11767278-B2 | Plant extract compositions for forming protective coatings | CUTA, SHARPIN, BROX | PRKCA 1628/4885PRKCE 1133/4885PRKCQ 1529/4885 |
| US-20230380435-A1 | METHOD FOR PREPARING AND PRESERVING SANITIZED PRODUCTS | TET2, SI, CAT | PRKCA 1477/4885PRKCE 1808/4885PRKCQ 2089/4885 |
| US-20180044276-A1 | PLANT EXTRACT COMPOSITIONS FOR FORMING PROTECTIVE COATINGS | CUTA, SHARPIN, BROX | PRKCA 1628/4885PRKCE 1133/4885PRKCQ 1529/4885 |
| US-20180179401-A1 | Precursor Compounds for Molecular Coatings | H1-10, CD209, PNISR | PRKCA 3741/4885PRKCE 3198/4885PRKCQ 2795/4885 |
| US-11723377-B2 | Method for preparing and preserving sanitized products | TET2, SI, CAT | PRKCA 1477/4885PRKCE 1808/4885PRKCQ 2089/4885 |
| US-20170332650-A1 | METHOD FOR PREPARING AND PRESERVING SANITIZED PRODUCTS | TET2, SI, CAT | PRKCA 1477/4885PRKCE 1808/4885PRKCQ 2089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.